Radiotherapy versus radiotherapy plus chemotherapy in early stage follicular lymphoma

• Country Australia, Canada, New Zealand
• organs None
• Specialty None

Progressive Exercise for Anabolism in Kidney Disease

• Country Australia
• organs None
• Specialty None

Sleep disruption in quadriplegia – A pilot study exploring whether 3mg melatonin induces sleep

• Country Australia
• organs None
• Specialty None

Methylphenidate for Borderline Personality Disorder in Adolescents

• Country Australia
• organs None
• Specialty None

A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid Tumors The purpose of this study is to evaluate MEDI0562 in combination with immune therapeutic agents in adult subjects with select advanced solid tumors.

• Country Australia, France, Netherlands, United States
• organs None
• Specialty None

Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis To assess the efficacy of two different treatment regimens of etanercept in psoriasis subjects with psoriatic arthritis with respect to both the skin and joint manifestations.

• Country Argentina, Australia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Saudi Arabia, Serbia, Spain, Sweden, Switzerland, Taiwan, Province of China, Turkey, United Kingdom
• organs None
• Specialty None

Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study The AC-055B201/MUSIC study is a Phase II study, comparing one dose of ACT-064922 (macitentan) 10 mg with placebo in patients with idiopathic pulmonary fibrosis (IPF). The main study object...

• Country Australia, Canada, France, Germany, Israel, Italy, Slovenia, South Africa, Spain, Sweden, Turkey, United States
• organs None
• Specialty None

Novel treatments for alcohol dependence: A randomized controlled trial of structured stepped-care intervention for psychiatric comorbidity

• Country Australia
• organs None
• Specialty None

A Phase II study in adult patients with newly-diagnosed chronic myeloid leukaemia of initial intensified Glivec® therapy, and sequential combination therapy for non-responders. With Protocol Amendments October 2004: to include an Extension Phase of the Study

• Country Australia
• organs None
• Specialty None

Biomarker Sub-study to the VYTUL Study

• Country Australia
• organs None
• Specialty None